Average Co-Inventor Count = 3.88
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (27 from 2,405 patents)
2. Merck + Co., Inc. (23 from 4,770 patents)
3. Visen Medical, Inc. (2 from 39 patents)
4. Other (1 from 832,680 patents)
5. Merch Sharp & Dohme Ltd (1 from 4 patents)
51 patents:
1. 9951079 - Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
2. 9861620 - Substituted quinolizine derivatives useful as HIV integrase inhibitors
3. 9714243 - 4-pyridinonetriazine derivatives as HIV integrase inhibitors
4. 9707234 - Spirocyclic hetercycle compounds useful as HIV integrase inhibitors
5. 9694089 - Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
6. 9643982 - Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
7. 8710076 - 2,5-disubstituted piperidine orexin receptor antagonists
8. 8703770 - Pyridazine carboxamide orexin receptor antagonists
9. 8691827 - Amino tetrahydro-pyridopyrimidine PDE10 inhibitors
10. 8685961 - Diazepan orexin receptor antagonists
11. 8685370 - Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
12. 8669272 - 2,5-disubstituted piperidine orexin receptor antagonists
13. 8637513 - Heterocycle phenyl amide T-type calcium channel antagonists
14. 8623863 - Disubstituted azepan orexin receptor antagonists
15. 8618102 - Bridged diazepan orexin receptor antagonists